Clinical Trial Update: EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for EPOgen and restrictive transfusions in cardiac surgery shows termination with posted results in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery
• Coronary Artery Bypass Grafting
• Heart Valve Disease

Drugs mentioned

• Epogen (epoetin alfa)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cardiac Surgery-CABG, Cardiac Valve Replacement | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-09-14